Nationwide implementation of stereotactic radiotherapy: The challenges of initial training and continuing professional education

被引：4

作者：

Bibault, J. -E. ^{[1
,2
]}

Denis, F. ^{[3
,4
,5
]}

Marchesi, V. ^{[7
]}

Lisbona, A. ^{[6
]}

Noel, G. ^{[5
,8
]}

Mahe, M. A. ^{[4
,5
,6
]}

机构：

[1] Univ Lille 2, Serv Univ Radiotherapie, Ctr Oscar Lambret, F-59020 Lille, France

[2] Ctr Antoine Beclere, Soc Francaise Jeunes Radiotherapeutes Oncol, F-75006 Paris, France

[3] Ctr Jean Bernard, F-72000 Le Mans, France

[4] Assoc Format Continue Oncol Radiotherapie, F-72003 Le Mans 1, France

[5] Ctr Antoine Beclere, Soc Francaise Radiotherapie Oncol, F-75006 Paris, France

[6] Inst Cancerol Ouest Rene Gauducheau, F-44805 St Herblain, France

[7] Inst Cancerol Lorraine, F-54519 Vandoeuvre Les Nancy, France

[8] Ctr Paul Strauss, Serv Univ Radiotherapie, F-67065 Strasbourg, France

来源：

CANCER RADIOTHERAPIE | 2014年 / 18卷 / 5-6期

关键词：

Learning; Medical physicist; Radiation oncologist; Stereotactic irradiation;

D O I：

10.1016/j.canrad.2014.06.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Stereotactic body radiation therapy is a rapidly growing advanced treatment technique that delivers high radiation dose with great precision. The implementation of stereotactic body radiation therapy should be associated with a specific initial training and continuing professional education for radiation oncologists and medical physicists. The creation of a French stereotactic body radiation therapy group gathering radiation oncologists (SFRO and AFCOR) and medical physicists (SFPM) is mandatory in order to create dedicated national guidelines, prospective databases and to promote clinical trials in this field. (C) 2014 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：387 / 390

页数：4

共 14 条

[1] Radiobiology of ablative dose in stereotactic irradiation: Update of the data [J].

Antoni, D. N. ;

Burckel, H. ;

Josset, E. ;

Noel, G. ;

Mornex, F. .

CANCER RADIOTHERAPIE, 2014, 18 (04) :264-269

[2] Assessment of the response following stereotactic irradiation of lung primary tumours and metastases [J].

Barillot, I. ;

Munier, O. ;

Hatime, M. ;

Mornex, F. .

CANCER RADIOTHERAPIE, 2014, 18 (04) :308-312

[3] Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity [J].

Bibault, Jean-Emmanuel ;

Dewas, Sylvain ;

Vautravers-Dewas, Claire ;

Hollebecque, Antoine ;

Jarraya, Hajer ;

Lacornerie, Thomas ;

Lartigau, Eric ;

Mirabel, Xavier .

PLOS ONE, 2013, 8 (10)

[4] STEREOTAXIC HIGH-DOSE FRACTION RADIATION-THERAPY OF EXTRACRANIAL TUMORS USING AN ACCELERATOR - CLINICAL-EXPERIENCE OF THE FIRST 31 PATIENTS [J].

BLOMGREN, H ;

LAX, I ;

NASLUND, I ;

SVANSTROM, R .

ACTA ONCOLOGICA, 1995, 34 (06) :861-870

[5]

Centre Leon-Berard. Formation stereotaxie, 2013, FORM STER

[6] White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment [J].

Chauvet, B. ;

Mahe, M. -A. ;

Maingon, P. ;

Mazeron, J. -J. ;

Mornex, F. .

CANCER RADIOTHERAPIE, 2013, 17 :S2-S72

[7]

Dewas S, 2008, CANC RADIOTHER

[8]

diu-radiotherapie.com [page d'accueil sur Internet], 2014, SIT DIPL INT U HAUT

[9]

Institut National du Cancer, 2014, PLAN CANC

[10]

Institut Sainte-Catherine, 2014, AT 2014 TECHN HAUT P

← 1 2 →